In a recent filing with regulatory authorities, ASP Isotopes (ASPI, Financial) revealed that its Chief Executive Officer, Paul Mann, completed a significant sale of company stock. The transaction, executed on April 15th, involved the sale of 950,000 shares, stemming from an option exercise.
The sale garnered a total value of approximately $5.33 million. This move by the CEO reflects a substantial personal stake adjustment in the company, although further details on the implications of this sale for the company or its stock performance were not disclosed in the filing.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for ASP Isotopes Inc (ASPI, Financial) is $6.50 with a high estimate of $8.50 and a low estimate of $4.50. The average target implies an upside of 11.30% from the current price of $5.84. More detailed estimate data can be found on the ASP Isotopes Inc (ASPI) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, ASP Isotopes Inc's (ASPI, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
